These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26021984)

  • 1. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
    Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
    BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
    Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.
    Mir H; Singh R; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2015 Apr; 6(12):9985-98. PubMed ID: 25888629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
    Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
    Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
    Huang Y; Li DJ; Wang MY; Cheng HD
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
    Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
    Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W; Liu Y; Zhou W; Si L; Ren L
    PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
    Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
    Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
    Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
    Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.
    Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM
    Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
    PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
    Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
    Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCL16-CXCR6 chemokine axis in glial tumors.
    Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
    J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y; Hou X; Ti Y; Bu P
    Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.